Eph/ephrin signaling in epidermal differentiation and disease

Seminars in Cell and Developmental Biology

Volumn 23, Issue 1, 2012, Pages 92-101

  Lin, Samantha ^a   Wang, Bingcheng ^b   Getsios, Spiro ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cadherin; Cell adhesion; Cell cell communication; Desmosome; EphA2; Epithelial

Indexed keywords

EPHRIN; EPHRIN A1; EPHRIN A2; EPHRIN A3; EPHRIN A4; EPHRIN A5; EPHRIN B1; EPHRIN B2; EPHRIN B3; EPHRIN RECEPTOR; EPHRIN RECEPTOR A1; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR A4; EPHRIN RECEPTOR A7; EPHRIN RECEPTOR B1; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B3; EPHRIN RECEPTOR B4; EPHRIN RECEPTOR B6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

BASEMENT MEMBRANE; CELL ADHESION; CELL COMMUNICATION; CELL CONTACT; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL JUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; HAIR FOLLICLE; HAIR GROWTH; HUMAN; KERATINOCYTE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SKIN CANCER; SKIN DISEASE; SKIN INFLAMMATION; SQUAMOUS EPITHELIUM; WOUND HEALING IMPAIRMENT;

MAMMALIA;

EID: 84857444836     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.10.017     Document Type: Review

References (129)

1. Blanpain C., Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 2009, 10(3):207-217.
2. Koster M.I., Roop D.R. Mechanisms regulating epithelial stratification. Annu Rev Cell Dev Biol 2007, 23:93-113.
3. Proksch E., Brandner J.M., Jensen J.M. The skin: an indispensable barrier. Exp Dermatol 2008, 17(12):1063-1072.
4. Green K.J., Simpson C.L. Desmosomes: new perspectives on a classic. J Invest Dermatol 2007, 127(11):2499-2515.
5. Gumbiner B.M. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 2005, 6(8):622-634.
6. Jensen P.J., Telegan B., Lavker R.M., Wheelock M.J. E-cadherin and P-cadherin have partially redundant roles in human epidermal stratification. Cell Tissue Res 1997, 288(2):307-316.
7. Niessen C.M. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007, 127(11):2525-2532.
8. Tinkle C.L., Pasolli H.A., Stokes N., Fuchs E. New insights into cadherin function in epidermal sheet formation and maintenance of tissue integrity. Proc Natl Acad Sci USA 2008, 105(40):15405-15410.
9. Tunggal J.A., Helfrich I., Schmitz A., Schwarz H., Gunzel D., Fromm M., et al. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J 2005, 24(6):1146-1156.
10. Wheelock M.J., Jensen P.J. Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol 1992, 117(2):415-425.
11. Panelos J., Massi D. Emerging role of Notch signaling in epidermal differentiation and skin cancer. Cancer Biol Ther 2009, 8(21):1986-1993.
12. Watt F.M., Estrach S., Ambler C.A. Epidermal Notch signalling: differentiation, cancer and adhesion. Curr Opin Cell Biol 2008, 20(2):171-179.
13. Rangarajan A., Talora C., Okuyama R., Nicolas M., Mammucari C., Oh H., et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001, 20(13):3427-3436.
14. Genander M., Holmberg J., Frisen J. Ephrins negatively regulate cell proliferation in the epidermis and hair follicle. Stem Cells 2010, 28(7):1196-1205.
15. Guo H., Miao H., Gerber L., Singh J., Denning M.F., Gilliam A.C., et al. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Res 2006, 66(14):7050-7058.
16. Lin S., Gordon K., Kaplan N., Getsios S. Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1. Mol Biol Cell 2010, 21(22):3902-3914.
17. Walsh R., Blumenberg M. Specific and shared targets of ephrin A signaling in epidermal keratinocytes. J Biol Chem 2011, 286(11):9419-9428.
18. Egawa G., Osawa M., Uemura A., Miyachi Y., Nishikawa S. Transient expression of ephrin b2 in perinatal skin is required for maintenance of keratinocyte homeostasis. J Invest Dermatol 2009, 129(10):2386-2395.
19. Moss A., Alvares D., Meredith-Middleton J., Robinson M., Slater R., Hunt S.P., et al. Ephrin-A4 inhibits sensory neurite outgrowth and is regulated by neonatal skin wounding. Eur J Neurosci 2005, 22(10):2413-2421.
20. Munthe E., Finne E.F., Aasheim H.C. Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells. BMC Immunol 2004, 5:9.
21. Udayakumar D., Zhang G., Ji Z., Njauw C.N., Mroz P., Tsao H. Epha2 is a critical oncogene in melanoma. Oncogene 2011.
22. Vihanto M.M., Plock J., Erni D., Frey B.M., Frey F.J., Huynh-Do U. Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J 2005, 19(12):1689-1691.
23. Yang G., Zhang G., Pittelkow M.R., Ramoni M., Tsao H. Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J Invest Dermatol 2006, 126(11):2490-2506.
24. Lackmann M., Boyd A.W. Eph, a protein family coming of age: more confusion, insight, or complexity?. Sci Signal 2008, 1(15):re2.
25. Pasquale E.B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010, 10(3):165-180.
26. Pasquale E.B. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 2005, 6(6):462-475.
27. Gale N.W., Holland S.J., Valenzuela D.M., Flenniken A., Pan L., Ryan T.E., et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 1996, 17(1):9-19.
28. Himanen J.P., Chumley M.J., Lackmann M., Li C., Barton W.A., Jeffrey P.D., et al. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci 2004, 7(5):501-509.
29. Pasquale E.B. Eph-ephrin promiscuity is now crystal clear. Nat Neurosci 2004, 7(5):417-418.
30. Hiramoto-Yamaki N., Takeuchi S., Ueda S., Harada K., Fujimoto S., Negishi M., et al. Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. J Cell Biol 2010, 190(3):461-477.
31. Miao H., Li D.Q., Mukherjee A., Guo H., Petty A., Cutter J., et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 2009, 16(1):9-20.
32. Noren N.K., Yang N.Y., Silldorff M., Mutyala R., Pasquale E.B. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. Biochem J 2009, 422(3):433-442.
33. Taddei M.L., Parri M., Angelucci A., Onnis B., Bianchini F., Giannoni E., et al. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am J Pathol 2009, 174(4):1492-1503.
34. Truitt L., Freywald T., DeCoteau J., Sharfe N., Freywald A. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells. Cancer Res 2010, 70(3):1141-1153.
35. Kullander K., Mather N.K., Diella F., Dottori M., Boyd A.W., Klein R. Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo. Neuron 2001, 29(1):73-84.
36. Easty D.J., Hill S.P., Hsu M.Y., Fallowfield M.E., Florenes V.A., Herlyn M., et al. Up-regulation of ephrin-A1 during melanoma progression. Int J Cancer 1999, 84(5):494-501.
37. Miao H., Wang B. Eph/ephrin signaling in epithelial development and homeostasis. Int J Biochem Cell Biol 2009, 41(4):762-770.
38. Pasquale E.B. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008, 133(1):38-52.
39. Pitulescu M.E., Adams R.H. Eph/ephrin molecules-a hub for signaling and endocytosis. Genes Dev 2010, 24(22):2480-2492.
40. Herath N.I., Boyd A.W. The role of Eph receptors and ephrin ligands in colorectal cancer. Int J Cancer 2010, 126(9):2003-2011.
41. Kojima T., Chung T.Y., Chang J.H., Sayegh R., Casanova F.H., Azar D.T. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas. Cornea 2007, 26(5):569-578.
42. Merlos-Suarez A., Batlle E. Eph-ephrin signalling in adult tissues and cancer. Curr Opin Cell Biol 2008, 20(2):194-200.
43. Hafner C., Becker B., Landthaler M., Vogt T. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol 2006, 19(10):1369-1377.
44. Alford S.C., Bazowski J., Lorimer H., Elowe S., Howard P.L. Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers. Exp Cell Res 2007, 313(20):4170-4179.
45. Aasheim H.C., Munthe E., Funderud S., Smeland E.B., Beiske K., Logtenberg T. A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood 2000, 95(1):221-230.
46. Hattori M., Osterfield M., Flanagan J.G. Regulated cleavage of a contact-mediated axon repellent. Science 2000, 289(5483):1360-1365.
47. Fuchs E. Scratching the surface of skin development. Nature 2007, 445(7130):834-842.
48. Lavker R.M., Sun T.T., Oshima H., Barrandon Y., Akiyama M., Ferraris C., et al. Hair follicle stem cells. J Investig Dermatol Symp Proc 2003, 8(1):28-38.
49. Tumbar T., Guasch G., Greco V., Blanpain C., Lowry W.E., Rendl M., et al. Defining the epithelial stem cell niche in skin. Science 2004, 303(5656):359-363.
50. Midorikawa T., Chikazawa T., Yoshino T., Takada K., Arase S. Different gene expression profile observed in dermal papilla cells related to androgenic alopecia by DNA macroarray analysis. J Dermatol Sci 2004, 36(1):25-32.
51. Coulthard M.G., Lickliter J.D., Subanesan N., Chen K., Webb G.C., Lowry A.J., et al. Characterization of the Epha1 receptor tyrosine kinase: expression in epithelial tissues. Growth Factors 2001, 18(4):303-317.
52. Yamada Y., Midorikawa T., Oura H., Yoshino T., Ohdera M., Kubo Y., et al. Ephrin-A3 not only increases the density of hair follicles but also accelerates anagen development in neonatal mice. J Dermatol Sci 2008, 52(3):178-185.
53. Qin H., Noberini R., Huan X., Shi J., Pasquale E.B., Song J. Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity. J Biol Chem 2004, 285(1):644-654.
54. Singla N., Goldgur Y., Xu K., Paavilainen S., Nikolov D.B., Himanen J.P. Crystal structure of the ligand-binding domain of the promiscuous EphA4 receptor reveals two distinct conformations. Biochem Biophys Res Commun 2010, 399(4):555-559.
55. Miao H., Nickel C.H., Cantley L.G., Bruggeman L.A., Bennardo L.N., Wang B. EphA kinase activation regulates HGF-induced epithelial branching morphogenesis. J Cell Biol 2003, 162(7):1281-1292.
56. Miao H., Wei B.R., Peehl D.M., Li Q., Alexandrou T., Schelling J.R., et al. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 2001, 3(5):527-530.
57. Larsen A.B., Stockhausen M.T., Poulsen H.S. Cell adhesion and EGFR activation regulate EphA2 expression in cancer. Cell Signal 2010, 22(4):636-644.
58. Macrae M., Neve R.M., Rodriguez-Viciana P., Haqq C., Yeh J., Chen C., et al. A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 2005, 8(2):111-118.
59. Simpson C.L., Kojima S., Getsios S. RNA interference in keratinocytes and an organotypic model of human epidermis. Methods Mol Biol 2010, 585:127-146.
60. Campbell T.N., Davy A., Liu Y., Arcellana-Panlilio M., Robbins S.M. Distinct membrane compartmentalization and signaling of ephrin-A5 and ephrin-B1. Biochem Biophys Res Commun 2008, 375(3):362-366.
61. Gauthier L.R., Robbins S.M. Ephrin signaling: one raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them?. Life Sci 2003, 74(2-3):207-216.
62. Kao T.J., Kania A. Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance. Neuron 2011, 71(1):76-91.
63. Marquardt T., Shirasaki R., Ghosh S., Andrews S.E., Carter N., Hunter T., et al. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 2005, 121(1):127-139.
64. Dudanova I., Klein R. The axon's balancing act: cis- and trans-interactions between Ephs and ephrins. Neuron 2011, 71(1):1-3.
65. Miura K., Nam J.M., Kojima C., Mochizuki N., Sabe H. EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts. Mol Biol Cell 2009, 20(7):1949-1959.
66. Orsulic S., Kemler R. Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. J Cell Sci 2000, 113(Pt 10):1793-1802.
67. Tanaka M., Kamata R., Sakai R. EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability. J Biol Chem 2005, 280(51):42375-42382.
68. Zantek N.D., Azimi M., Fedor-Chaiken M., Wang B., Brackenbury R., Kinch M.S. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ 1999, 10(9):629-638.
69. Fang W.B., Brantley-Sieders D.M., Parker M.A., Reith A.D., Chen J. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis. Oncogene 2005, 24(53):7859-7868.
70. Jorgensen C., Sherman A., Chen G.I., Pasculescu A., Poliakov A., Hsiung M., et al. Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science 2009, 326(5959):1502-1509.
71. Walker-Daniels J., Riese D.J., Kinch M.S. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol Cancer Res 2002, 1(1):79-87.
72. Zhuang G., Hunter S., Hwang Y., Chen J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-kinase-dependent Rac1 activation. J Biol Chem 2007, 282(4):2683-2694.
73. Duxbury M.S., Ito H., Zinner M.J., Ashley S.W., Whang E.E. Ligation of EphA2 by ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Biochem Biophys Res Commun 2004, 320(4):1096-1102.
74. Wykosky J., Palma E., Gibo D.M., Ringler S., Turner C.P., Debinski W. Soluble monomeric ephrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor. Oncogene 2008, 27(58):7260-7273.
75. Larsen A.B., Pedersen M.W., Stockhausen M.T., Grandal M.V., van Deurs B., Poulsen H.S. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. Mol Cancer Res 2007, 5(3):283-293.
76. Yoo S., Kim Y., Noh H., Lee H., Park E., Park S. Endocytosis of EphA receptors is essential for the proper development of the retinocollicular topographic map. EMBO J 2011, 30(8):1593-1607.
77. Fasen K., Cerretti D.P., Huynh-Do U. Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway. Traffic 2008, 9(2):251-266.
78. Kim J., Lee H., Kim Y., Yoo S., Park E., Park S. The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors. Mol Cell Biol 2010, 30(7):1582-1592.
79. Sharfe N., Freywald A., Toro A., Roifman C.M. Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells. J Immunol 2003, 170(12):6024-6032.
80. Wang Y., Ota S., Kataoka H., Kanamori M., Li Z., Band H., et al. Negative regulation of EphA2 receptor by Cbl. Biochem Biophys Res Commun 2002, 296(1):214-220.
81. Leone M., Cellitti J., Pellecchia M. NMR studies of a heterotypic Sam-Sam domain association: the interaction between the lipid phosphatase Ship2 and the EphA2 receptor. Biochemistry 2008, 47(48):12721-12728.
82. Nievergall E., Janes P.W., Stegmayer C., Vail M.E., Haj F.G., Teng S.W., et al. PTP1B regulates Eph receptor function and trafficking. J Cell Biol 2011, 191(6):1189-1203.
83. Parri M., Buricchi F., Taddei M.L., Giannoni E., Raugei G., Ramponi G., et al. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J Biol Chem 2005, 280(40):34008-34018.
84. Zhang T., Hua R., Xiao W., Burdon K.P., Bhattacharya S.S., Craig J.E., et al. Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract. Hum Mutat 2009, 30(5):E603-E611.
85. Janes P.W., Saha N., Barton W.A., Kolev M.V., Wimmer-Kleikamp S.H., Nievergall E., et al. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 2005, 123(2):291-304.
86. Janes P.W., Wimmer-Kleikamp S.H., Frangakis A.S., Treble K., Griesshaber B., Sabet O., et al. Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol 2009, 7(10):e1000215.
87. Salaita K., Nair P.M., Petit R.S., Neve R.M., Das D., Gray J.W., et al. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 2010, 327(5971):1380-1385.
88. Weber S., Niessen M.T., Prox J., Lullmann-Rauch R., Schmitz A., Schwanbeck R., et al. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development 2011, 138(3):495-505.
89. Himanen J.P., Goldgur Y., Miao H., Myshkin E., Guo H., Buck M., et al. Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep 2009, 10(7):722-728.
90. Himanen J.P., Yermekbayeva L., Janes P.W., Walker J.R., Xu K., Atapattu L., et al. Architecture of Eph receptor clusters. Proc Natl Acad Sci USA 2010, 107(24):10860-10865.
91. Seiradake E., Harlos K., Sutton G., Aricescu A.R., Jones E.Y. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat Struct Mol Biol 2010, 17(4):398-402.
92. Michels C., Aghdam S.Y., Niessen C.M. Cadherin-mediated regulation of tight junctions in stratifying epithelia. Ann N Y Acad Sci 2009, 1165:163-168.
93. Getsios S., Simpson C.L., Kojima S., Harmon R., Sheu L.J., Dusek R.L., et al. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 2009, 185(7):1243-1258.
94. Cowan C.W., Shao Y.R., Sahin M., Shamah S.M., Lin M.Z., Greer P.L., et al. Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron 2005, 46(2):205-217.
95. Fang W.B., Brantley-Sieders D.M., Hwang Y., Ham A.J., Chen J. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase. J Biol Chem 2008, 283(23):16017-16026.
96. Murai K.K., Pasquale E.B. New exchanges in Eph-dependent growth cone dynamics. Neuron 2005, 46(2):161-163.
97. Noren N.K., Pasquale E.B. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal 2004, 16(6):655-666.
98. Rosas O.R., Figueroa J.D., Torrado A.I., Rivera M., Santiago J.M., Konig-Toro F., et al. Expression and activation of ephexin is altered after spinal cord injury. Dev Neurobiol 2011, 71(7):595-607.
99. Schmucker D., Zipursky S.L. Signaling downstream of Eph receptors and ephrin ligands. Cell 2001, 105(6):701-704.
100. Shamah S.M., Lin M.Z., Goldberg J.L., Estrach S., Sahin M., Hu L., et al. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 2001, 105(2):233-244.
101. Wimmer-Kleikamp S.H., Nievergall E., Gegenbauer K., Adikari S., Mansour M., Yeadon T., et al. Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells. Blood 2008, 112(3):721-732.
102. Fang W.B., Ireton R.C., Zhuang G., Takahashi T., Reynolds A., Chen J. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism. J Cell Sci 2008, 121(Pt 3):358-368.
103. Kubo A., Nagao K., Yokouchi M., Sasaki H., Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009, 206(13):2937-2946.
104. De Benedetto A., Rafaels N.M., McGirt L.Y., Ivanov A.I., Georas S.N., Cheadle C., et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 2011, 127(3):773-786. e1-7.
105. Bocharov E.V., Mayzel M.L., Volynsky P.E., Goncharuk M.V., Ermolyuk Y.S., Schulga A.A., et al. Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J Biol Chem 2008, 283(43):29385-29395.
106. Bocharov E.V., Mayzel M.L., Volynsky P.E., Mineev K.S., Tkach E.N., Ermolyuk Y.S., et al. Left-handed dimer of EphA2 transmembrane domain: helix packing diversity among receptor tyrosine kinases. Biophys J 2010, 98(5):881-889.
107. Behne M.J., Barry N.P., Hanson K.M., Aronchik I., Clegg R.W., Gratton E., et al. Neonatal development of the stratum corneum pH gradient: localization and mechanisms leading to emergence of optimal barrier function. J Invest Dermatol 2003, 120(6):998-1006.
108. Zhang G., Njauw C.N., Park J.M., Naruse C., Asano M., Tsao H. EphA2 is an essential mediator of UV radiation-induced apoptosis. Cancer Res 2008, 68(6):1691-1696.
109. Calautti E., Li J., Saoncella S., Brissette J.L., Goetinck P.F. Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 2005, 280(38):32856-32865.
110. Thrash B.R., Menges C.W., Pierce R.H., McCance D.J. AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J Biol Chem 2006, 281(17):12155-12162.
111. Plonka P.M., Passeron T., Brenner M., Tobin D.J., Shibahara S., Thomas A., et al. What are melanocytes really doing all day long?. Exp Dermatol 2009, 18(9):799-819.
112. Chen L.X., He Y.J., Zhao S.Z., Wu J.G., Wang J.T., Zhu L.M., et al. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model. Cancer Biol Ther 2011, 11(2):229-235.
113. Eskandarpour M., Huang F., Reeves K.A., Clark E., Hansson J. Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro. Int J Cancer 2009, 124(1):16-26.
114. Hendrix M.J., Seftor E.A., Hess A.R., Seftor R.E. Molecular plasticity of human melanoma cells. Oncogene 2003, 22(20):3070-3075.
115. Hendrix M.J., Seftor E.A., Kirschmann D.A., Quaranta V., Seftor R.E. Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci 2003, 995:151-161.
116. Hess A.R., Seftor E.A., Gruman L.M., Kinch M.S., Seftor R.E., Hendrix M.J. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 2006, 5(2):228-233.
117. Margaryan N.V., Strizzi L., Abbott D.E., Seftor E.A., Rao M.S., Hendrix M.J., et al. EphA2 as a promoter of melanoma tumorigenicity. Cancer Biol Ther 2009, 8(3):279-288.
118. Parri M., Taddei M.L., Bianchini F., Calorini L., Chiarugi P. EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res 2009, 69(5):2072-2081.
119. Quintanilla M., Brown K., Ramsden M., Balmain A. Carcinogen-specific mutation and amplification of Ha-Ras during mouse skin carcinogenesis. Nature 1986, 322(6074):78-80.
120. Yamazaki T., Masuda J., Omori T., Usui R., Akiyama H., Maru Y. EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility. J Cell Sci 2009, 122(Pt 2):243-255.
121. Guttman-Yassky E., Nograles K.E., Krueger J.G. Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: clinical and pathologic concepts. J Allergy Clin Immunol 2011, 127(5):1110-1118.
122. Kulski J.K., Kenworthy W., Bellgard M., Taplin R., Okamoto K., Oka A., et al. Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. J Mol Med (Berl) 2005, 83(12):964-975.
123. Piruzian E., Bruskin S., Ishkin A., Abdeev R., Moshkovskii S., Melnik S., et al. Integrated network analysis of transcriptomic and proteomic data in psoriasis. BMC Syst Biol 2010, 4(41).
124. Rosenberg I.M., Goke M., Kanai M., Reinecker H.C., Podolsky D.K. Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. Am J Physiol 1997, 273(4 Pt 1):G824-G832.
125. Trautmann A., Altznauer F., Akdis M., Simon H.U., Disch R., Brocker E.B., et al. The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol 2001, 117(4):927-934.
126. Dumortier A., Durham A.D., Di Piazza M., Vauclair S., Koch U., Ferrand G., et al. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS ONE 2010, 5(2):e9258.
127. Amagai M., Hashimoto T., Green K.J., Shimizu N., Nishikawa T. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995, 104(6):895-901.
128. Stanley J.R. Autoantibodies against adhesion molecules and structures in blistering skin diseases. J Exp Med 1995, 181(1):1-4.
129. Akiyama M. ABCA12 mutations and autosomal recessive congenital ichthyosis: a review of genotype/phenotype correlations and of pathogenetic concepts. Hum Mutat 2010, 31(10):1090-1096.